Business
Australia, Israel top destinations of Canadian medical cannabis exports
Australia and Israel were the top markets for Canada’s medical cannabis exporters last year, as the quantity of flower shipped overseas continued to surge, according to new figures shared by Health Canada with MJBizDaily.
In the April 2022-March 2023 fiscal year, Canada’s exports of medical marijuana flower were 59,986 kilograms (roughly 132,200 pounds), a 48% increase over the previous year’s 40,640 kilograms.
The vast majority of exports, however, went to only three countries, meaning exporters risk being dependent on a very small number of markets.
Almost 80% went to Australia and Israel, which together were responsible for importing 47,332 kilograms of Canadian flower.
Germany was the next-biggest importer, accounting for 9,560 kilograms, or approximately 16% of the total, according to the Health Canada data.
Since 2017, Canada has exported 126,025 kilograms of medical cannabis flower for commercial and scientific use.
In total, the value of Canada’s medical cannabis exports last year increased to 160 million Canadian dollars ($118 million), about 50% more than fiscal 2021-22’s total.
Aurora Cannabis CEO Miguel Martin told MJBizDaily in a phone interview he sees medical cannabis exports as a long-term play for his company.
“It’s a big opportunity. The margins are about 2.5 times what they are in Canadian rec, and not declining,” Martin noted, referring to Canada’s recreational cannabis market.
Australia, meanwhile, was the top importer of Canadian cannabis extracts.
Among the top five importing countries, Australia accounted for 93%, or 8,392 liters (2,217 gallons), of the total 9,042 liters of medical cannabis extract products exported.
The Cayman Islands was second, receiving 320 liters of Canadian exports.
Brazil, Barbados and South Africa rounded out the top five last year, with 136 liters, 103 liters and 90 liters, respectively.
Driving export growth
Some of the factors driving Canadian cannabis exportsare:
- Increasingly higher-quality products in the Canadian domestic market, which remains saturated with competition and oversupply.
- Higher margins overseas, in part because of excise levies in Canada.
- Fewer competitors capable of competing internationally, given higher barriers to entry in most of those markets.
Aurora’s Martin said part of what is driving exports higher is the good reputation of Canadian products overseas.
“There’s a lot of equity and credibility for Canadian medical cannabis product,” he said.
But the export market is getting more competitive, with countries such as Colombia and Denmark aiming to grab more of Canada’s share.
Similarly, more nations have ambitions to be net exporters than there are countries with plans to import meaningful quantities, signaling competition in the import/export market will get more intense in the coming years.
Canadian licensed producers also risk becoming dependent on a handful of international markets, where regulations can sometimes change with little to no warning.
Martin said he’s confident more import markets will open up, as slow-moving regulations in some countries doesn’t allow production to keep pace with demand.
He pointed to Poland and the United Kingdom as nations with potential.
Martin said regulatory certainty is an important factor.
“One of the things for us is we want to be in markets where the regulatory framework is predictable – even if it’s slow,” he said.
Citing the German opportunity, Martin said that “gearing up for that is a way bigger opportunity than hoping and praying that something is going to happen in the Netherlands.”
Most importing countries require European Union-Good Manufacturing Practice (EU-GMP) certification, or something similar, which is costly and takes time to achieve.
“One of the more finite resources that is really important out there is EU-GMP flower. That’s a very expensive, very hard thing to do, and not a lot of people are doing it at scale, and all of those markets require it,” Martin said.
“When you see new markets come online, it’s not just the size, it’s who (is capable) of addressing it.
“As these markets come online, you’re going to see the same winners, and they’re usually multinationals.”
Exports seen rising
Deepak Anand, principal of ASDA Consultancy Services in Surrey, British Columbia, suggested that Canadian exports are gaining momentum, in part, because some countries that allow medical cannabis sales still don’t have enough domestic production to match demand.
Australia, he said, is licensing more cultivators but not enough to meet domestic consumption in the regulated market, meaning imports will still be needed to fill the gap.
But Anand warned that recent regulatory changes are creating potential headwinds for prospective exporters to Australia.
Starting in July, all imported medical cannabis products in Australia were required to comply with stricter import requirements.
“I think that will result in a little bit of a limiting of how much product actually is going to continue to go into Australia,” Anand said.
Anand has his eye on Portugal, which he expects to increase imports.
“A lot of people are now exporting to Portugal, with the intended market being Germany,” he said.
“There is quite a bit of money on the table from a revenue standpoint from exports.”
Source: https://mjbizdaily.com/australia-israel-top-destinations-of-canadian-medical-cannabis-exports/
Business
Alleged Crores Pharma Scam Mastermind Arrested from Surat
After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.
Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.
Fake Business Deals and Dishonoured Cheques Used in Fraud
Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.
In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”
Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.
Multiple Identities and Repeated Fraud Pattern
Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.
Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.
Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.
Multi-State Surveillance Leads to Arrest in Surat
A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.
Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.
Growing Threat of Corporate Identity Fraud
The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.
Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.
Experts Urge Stronger Due Diligence in High-Value Transactions
Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.
Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.
Business
EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices
A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.
Investigation Under Digital Markets Act Gains Momentum
The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.
Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.
Industry Groups Demand Swift Action
Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.
Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.
In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.
Google Denies Allegations
Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.
However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.
Potential Billion-Euro Penalties
If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.
Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.
Wider Implications for Big Tech
The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.
A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.
As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.
AI & Technology
Amazon Faces Potential Criminal Trial in Italy Over €1.2 Billion Tax Evasion Allegations
Milan: U.S. tech giant Amazon is facing the prospect of a major legal showdown in Italy, after prosecutors in Milan formally requested a court to move forward with criminal proceedings over alleged tax evasion totaling approximately ₹12,500 crore (€1.2 billion).
The case targets Amazon’s European division along with four senior executives, marking one of the most significant tax-related investigations involving a global e-commerce platform in Europe.
Trial Push Despite Multi-Million Euro Settlement
The move comes even after Amazon reached a financial settlement with Italian tax authorities in December, agreeing to pay around ₹5,500 crore (€527 million), including interest, to resolve part of the dispute.
Typically, such settlements lead to the closure of criminal investigations. However, Milan prosecutors have opted to proceed, signaling a tougher stance on alleged corporate tax violations.
A preliminary hearing is expected in the coming months, where a judge will decide whether to formally indict the company and its executives or dismiss the case.
Allegations of VAT Evasion Through Marketplace Sellers
At the center of the investigation are claims that Amazon’s platform enabled non-European Union sellers to avoid paying value-added tax (VAT) on goods sold to Italian consumers between 2019 and 2021.
Prosecutors allege that the company’s marketplace structure allowed thousands of foreign vendors—many reportedly based in China—to operate without fully disclosing their identities or tax obligations. This, authorities argue, led to substantial VAT losses for the Italian government.
Under Italian law, online platforms facilitating sales can be held partially liable if third-party sellers fail to comply with tax requirements, a key point in the prosecution’s case.
Italian Government Named as Affected Party
In their filing, prosecutors identified Italy’s Economy Ministry as the injured party, citing significant financial damage resulting from the alleged tax evasion.
Legal experts say the outcome of the case could have wide-ranging implications across the European Union, where VAT systems are harmonized and similar compliance rules apply to digital marketplaces.
Multiple Investigations Add to Pressure
The VAT probe is just one of several legal challenges facing Amazon in Italy. The European Public Prosecutor’s Office is reportedly examining additional tax-related issues covering more recent years.
Meanwhile, Milan authorities are pursuing separate investigations into alleged customs fraud linked to imports from China and whether Amazon maintained an undeclared “permanent establishment” in Italy—potentially exposing it to higher tax liabilities.
In a separate regulatory action, Italy’s data protection authority recently ordered an Amazon unit to stop using personal data from over 1,800 employees at a warehouse near Rome.
Amazon Denies Allegations
Amazon has consistently denied wrongdoing and indicated it will strongly contest the allegations in court if the case proceeds. The company has also warned that prolonged legal uncertainty could impact investor confidence and Italy’s appeal as a destination for international business.
Broader Impact on Europe’s Digital Economy
If the case moves to trial, it could become a landmark moment for the regulation of global e-commerce platforms in Europe. Governments across the region are increasingly scrutinizing how digital marketplaces handle tax compliance, especially in cross-border transactions.
With online retail continuing to expand, regulators are under mounting pressure to ensure that multinational platforms and third-party sellers adhere to the same tax rules as traditional businesses.
-
Business3 years agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business3 years agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business3 years agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business3 years agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business3 years agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business3 years agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business3 years agoCan Cannabis Help Seasonal Depression
-
Blogs3 years agoCannabis Art Is Flourishing On Etsy
